EQL PHARMA AB Free Cash Flow Generation Index
EQL PHARMA AB free cash flow generation index. EQL PHARMA AB (7JK) has a Free Cash Flow Generation Index of -0.03x as of March 2026. Free cash flow of €-436.00K represents 0% of operating cash flow (€16.79 Million). Read how much debt does EQL PHARMA AB carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of EQL PHARMA AB (2022–2026)
Free cash flow generation index of EQL PHARMA AB from 2022 to 2026. Historical FCF Generation Index trend for EQL PHARMA AB across 3 annual periods. Explore 7JK capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
EQL PHARMA AB Free Cash Flow Generation Index by Year (2022–2026)
EQL PHARMA AB free cash flow generation index by year from 2022 to 2026. Year-by-year Free Cash Flow Generation Index for EQL PHARMA AB. For the full cash flow conversion analysis, see EQL PHARMA AB operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | -1.37x | €-38.88 Million | €28.36 Million | €67.24 Million | ▼ -632.7% |
| 2023 | 0.26x | €7.11 Million | €27.62 Million | €20.51 Million | ▼ -45.5% |
| 2022 | 0.47x | €19.74 Million | €41.83 Million | €22.09 Million | — |